Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Membrane Asymmetry Regulating Transporters01:19

Membrane Asymmetry Regulating Transporters

Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Century of Progress on the Structure of APOB-100 in Atherogenic Lipoproteins.

Circulation research·2026
Same author

ABCA1-Mediated Structural Diversity of HDL Subspecies and Their Proposed Roles in Cardioprotection.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The congenital APOA1 K107del mutation disrupts the lipid-free conformation of monomeric APOA1 and impairs oligomerization.

Journal of lipid research·2025
Same author

Apolipoprotein A5 reduces clearance of VLDL by altering apolipoprotein E content.

Journal of lipid research·2025
Same author

Exchangeable APOA1 on HDL inhibits LDL binding to proteoglycans.

Journal of lipid research·2025

Related Experiment Video

Updated: Jul 15, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

ABCA1-induced cell surface binding sites for ApoA-I.

Charulatha Vedhachalam1, Amy B Ghering, W Sean Davidson

  • 1Division of GI/Nutrition, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-4318, USA.

Arteriosclerosis, Thrombosis, and Vascular Biology
|May 5, 2007
PubMed
Summary

This study reveals two high-affinity binding sites for apolipoprotein A-I (apoA-I) on cells expressing ABCA1. One site regulates, while the other facilitates high-density lipoprotein (HDL) assembly.

More Related Videos

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography
06:47

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography

Published on: August 25, 2023

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)
09:35

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)

Published on: November 29, 2014

Related Experiment Videos

Last Updated: Jul 15, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography
06:47

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography

Published on: August 25, 2023

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)
09:35

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)

Published on: November 29, 2014

Area of Science:

  • Biochemistry
  • Cell Biology
  • Lipid Metabolism

Background:

  • Apolipoprotein A-I (apoA-I) is the primary protein component of high-density lipoprotein (HDL).
  • ATP-binding cassette transporter A1 (ABCA1) plays a crucial role in cellular lipid efflux and HDL biogenesis.

Purpose of the Study:

  • To elucidate the interaction mechanisms between apoA-I and cells expressing ABCA1.
  • To characterize the binding sites and their functional implications.

Main Methods:

  • Utilized 125I-labeled wild-type (WT) and mutant apoA-I for binding studies.
  • Employed covalent cross-linking to identify direct apoA-I/ABCA1 interactions.
  • Analyzed cell-surface ABCA1 expression and apoA-I binding affinity.

Main Results:

  • Identified two distinct high-affinity apoA-I binding sites on ABCA1-expressing cells.
  • Demonstrated that direct apoA-I/ABCA1 interaction constitutes a low-capacity, regulatory site (approx. 10% of binding).
  • Showed that apoA-I/lipid interactions form a high-capacity site involved in nascent HDL assembly (approx. 90% of binding).

Conclusions:

  • ABCA1 activity generates distinct apoA-I binding sites with differing capacities and functions.
  • The direct apoA-I/ABCA1 interaction is regulatory, while apoA-I/lipid interactions are critical for HDL formation.